A rivalry between two drugmakers, Cogent Biosciences and Blueprint Medicines, has turned ugly. This ...
Needham & Company LLC reaffirmed a "hold" rating on shares of Cogent Biosciences in a research note ...
Facility provides additional funding for next steps of the Company’s growth, including the expected ...
Cogent Biosciences Inc [NASDAQ: COGT] closed the trading session at $5.99. The stocks have a year to...